Maria Martinez
NPI 1851990584 · Optometrist · Coral Gables, FL
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1851990584
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Sex
- Female
- Sole proprietor
- No
- License
- OPC5851 (FL)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
5 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
322 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Closure of Tear Duct Opening Using Plug68761 | 89 | $112 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 72 | $95 |
| Established Patient Complete Exam of Visual System92014 | 37 | $127 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 36 | $134 |
| Exam of Visual Field With Extended Testing92083 | 26 | $64 |
| New Patient Complete Exam of Visual System92004 | 24 | $151 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 24 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 706 | 269 |
| Bimatoprostbrand: Lumigan | 319 | 94 |
| Erythromycin Basebrand: Erythromycin | 314 | 242 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 171 | 84 |
| Cyclosporine | 123 | 72 |
| Cyclosporinebrand: Restasis | 98 | 33 |
| Timolol Maleate | 89 | 36 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$281 across 7 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2020-10-23
- Last updated
- 2023-10-24
- Certified
- 2023-10-24
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.